Skip to main content

Table 4 Changes in fasting blood measurements, resting energy expenditure and respiratory quotient

From: The effect of 12 weeks of aerobic, resistance or combination exercise training on cardiovascular risk factors in the overweight and obese in a randomized trial

 

Baseline

Week 8

Week 12

TG (mmol/L)

   

Control

1.25 ± 0.17

1.37 ± 0.19

1.48 ± 0.23

Aerobic

1.36 ± 0.19

1.29 ± 0.11

1.40 ± 0.16

Resistance

1.27 ± 0.12

1.21 ± 0.16

1.38 ± 0.18

Combination

1.10 ± 0.10

1.08 ± 0.10

1.36 ± 0.17*

TC (mmol/L)

   

Control

5.51 ± 0.29

5.88 ± 0.32

5.49 ± 0.28a

Aerobic

5.83 ± 0.32

5.72 ± 0.29

5.56 ± 0.37a

Resistance

5.49 ± 0.38

5.76 ± 0.36

6.15 ± 0.44* b

Combination

5.71 ± 0.31

5.74 ± 0.27

5.75 ± 0.26ab

HDL (mmol/L)

   

Control

1.42 ± 0.11

1.45 ± 0.11ab

1.35 ± 0.10a

Aerobic

1.38 ± 0.09

1.31 ± 0.08a

1.28 ± 0.07* a

Resistance

1.34 ± 0.08

1.44 ± 0.08b

1.44 ± 0.08* b

Combination

1.43 ± 0.11

1.44 ± 0.10ab

1.41 ± 0.11ab

LDL (mmol/L)

   

Control

3.51 ± 0.26

3.79 ± 0.31

3.47 ± 0.25a

Aerobic

3.89 ± 0.30

3.82 ± 0.27

3.64 ± 0.33a

Resistance

3.56 ± 0.33

3.76 ± 0.31

4.08 ± 0.36* b

Combination

3.78 ± 0.27

3.80 ± 0.22

3.71 ± 0.22a

NEFA (mmol/L)

   

Control

0.51 ± 0.03

0.45 ± 0.04a

0.48 ± 0.03

Aerobic

0.50 ± 0.04

0.59 ± 0.05b

0.47 ± 0.04

Resistance

0.49 ± 0.04

0.52 ± 0.04ab

0.54 ± 0.05

Combination

0.46 ± 0.03

0.49 ± 0.03ab

0.54 ± 0.04

Glucose (mmol/L)

   

Control

5.35 ± 0.13

5.46 ± 0.10

5.26 ± 0.18

Aerobic

5.68 ± 0.17

5.78 ± 0.18

5.73 ± 0.10

Resistance

5.81 ± 0.46

5.81 ± 0.17

5.77 ± 0.16

Combination

5.38 ± 0.13

5.31 ± 0.10

5.55 ± 0.13

Insulin (μUI/mL)

   

Control

14.89 ± 2.29

14.82 ± 1.66

14.76 ± 1.69

Aerobic

13.05 ± 1.01

16.67 ± 1.48*

15.87 ± 1.86

Resistance

13.98 ± 1.40

16.82 ± 1.33*

13.48 ± 1.24

Combination

14.24 ± 1.03

17.07 ± 1.33*

14.25 ± 1.25

ApoB48 (μg/mL)

   

Control

6.75 ± 0.74

6.23 ± 0.58

7.08 ± 0.77a

Aerobic

5.68 ± 0.59

5.57 ± 0.78

5.58 ± 0.77ab

Resistance

5.92 ± 1.05

4.54 ± 0.64

4.46 ± 0.45* b

Combination

5.30 ± 0.56

5.33 ± 0.82

5.04 ± 0.78ab

REE (kJ/day)

   

Control

6088.4 ± 392.7

 

6081.9 ± 384.8

Aerobic

6388.2 ± 281.2

 

6283.5 ± 264.6

Resistance

6468.3 ± 312.1

 

6431.2 ± 302.5

Combination

6328.2 ± 319.7

 

6252.1 ± 291.1

RQ

   

Control

0.84 ± 0.007

 

0.84 ± 0.012

Aerobic

0.84 ± 0.010

 

0.84 ± 0.014

Resistance

0.85 ± 0.016

 

0.81 ± 0.016*

Combination

0.83 ± 0.023

 

0.84 ± 0.017

  1. Values are mean ± SEM (n = 64) of fasting blood measurements at baseline, week 8 and week 12. Statistical significance from baseline (within groups) is indicated by * p < 0.05. Statistical differences between groups at week 8 or 12 with baseline as a covariate indicated by different superscripts p < 0.05. TG: triglyceride. TC: total cholesterol. HDL: high density lipoprotein. LDL: low density lipoprotein. NEFA: non-esterified fatty acid. ApoB48: apolipoprotein B48. REE: resting energy expenditure. RQ: respiratory quotient.